1 Introduction to Research & Analysis Reports 1.1 Bronchodilator Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Bronchodilator Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Bronchodilator Overall Market Size 2.1 United States Bronchodilator Market Size: 2021 VS 2027 2.2 United States Bronchodilator Revenue, Prospects & Forecasts: 2016-2027 2.3 United States Bronchodilator Sales: 2016-2027 3 Company Landscape 3.1 Top Bronchodilator Players in United States Market 3.2 Top United States Bronchodilator Companies Ranked by Revenue 3.3 United States Bronchodilator Revenue by Companies 3.4 United States Bronchodilator Sales by Companies 3.5 United States Bronchodilator Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Bronchodilator Companies in United States Market, by Revenue in 2020 3.7 Manufacturers Bronchodilator Product Type 3.8 Tier 1, Tier 2 and Tier 3 Bronchodilator Players in United States Market 3.8.1 List of Tier 1 Bronchodilator Companies in United States 3.8.2 List of Tier 2 and Tier 3 Bronchodilator Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Bronchodilator Market Size Markets, 2021 & 2027 4.1.2 Short-acting Bronchodilator 4.1.3 Long-acting Bronchodilator 4.2 By Type - United States Bronchodilator Revenue & Forecasts 4.2.1 By Type - United States Bronchodilator Revenue, 2016-2021 4.2.2 By Type - United States Bronchodilator Revenue, 2022-2027 4.2.3 By Type - United States Bronchodilator Revenue Market Share, 2016-2027 4.3 By Type - United States Bronchodilator Sales & Forecasts 4.3.1 By Type - United States Bronchodilator Sales, 2016-2021 4.3.2 By Type - United States Bronchodilator Sales, 2022-2027 4.3.3 By Type - United States Bronchodilator Sales Market Share, 2016-2027 4.4 By Type - United States Bronchodilator Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Bronchodilator Market Size, 2021 & 2027 5.1.2 Asthma 5.1.3 Chronic Obstructive Pulmonary Disease 5.1.4 Others 5.2 By Application - United States Bronchodilator Revenue & Forecasts 5.2.1 By Application - United States Bronchodilator Revenue, 2016-2021 5.2.2 By Application - United States Bronchodilator Revenue, 2022-2027 5.2.3 By Application - United States Bronchodilator Revenue Market Share, 2016-2027 5.3 By Application - United States Bronchodilator Sales & Forecasts 5.3.1 By Application - United States Bronchodilator Sales, 2016-2021 5.3.2 By Application - United States Bronchodilator Sales, 2022-2027 5.3.3 By Application - United States Bronchodilator Sales Market Share, 2016-2027 5.4 By Application - United States Bronchodilator Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 GlaxoSmithKline 6.1.1 GlaxoSmithKline Corporation Information 6.1.2 GlaxoSmithKline Overview 6.1.3 GlaxoSmithKline Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.1.4 GlaxoSmithKline Bronchodilator Product Description 6.1.5 GlaxoSmithKline Recent Developments 6.2 Roche 6.2.1 Roche Corporation Information 6.2.2 Roche Overview 6.2.3 Roche Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.2.4 Roche Bronchodilator Product Description 6.2.5 Roche Recent Developments 6.3 AstraZeneca 6.3.1 AstraZeneca Corporation Information 6.3.2 AstraZeneca Overview 6.3.3 AstraZeneca Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.3.4 AstraZeneca Bronchodilator Product Description 6.3.5 AstraZeneca Recent Developments 6.4 Boehringer Ingelheim 6.4.1 Boehringer Ingelheim Corporation Information 6.4.2 Boehringer Ingelheim Overview 6.4.3 Boehringer Ingelheim Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.4.4 Boehringer Ingelheim Bronchodilator Product Description 6.4.5 Boehringer Ingelheim Recent Developments 6.5 Amgen 6.5.1 Amgen Corporation Information 6.5.2 Amgen Overview 6.5.3 Amgen Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.5.4 Amgen Bronchodilator Product Description 6.5.5 Amgen Recent Developments 6.6 Kissei Pharmaceutical 6.6.1 Kissei Pharmaceutical Corporation Information 6.6.2 Kissei Pharmaceutical Overview 6.6.3 Kissei Pharmaceutical Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.6.4 Kissei Pharmaceutical Bronchodilator Product Description 6.6.5 Kissei Pharmaceutical Recent Developments 6.7 Mitsubishi Tanabe Pharma 6.7.1 Mitsubishi Tanabe Pharma Corporation Information 6.7.2 Mitsubishi Tanabe Pharma Overview 6.7.3 Mitsubishi Tanabe Pharma Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.7.4 Mitsubishi Tanabe Pharma Bronchodilator Product Description 6.7.5 Mitsubishi Tanabe Pharma Recent Developments 6.8 Sanofi 6.8.1 Sanofi Corporation Information 6.8.2 Sanofi Overview 6.8.3 Sanofi Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.8.4 Sanofi Bronchodilator Product Description 6.8.5 Sanofi Recent Developments 6.9 Theron Pharmaceuticals 6.9.1 Theron Pharmaceuticals Corporation Information 6.9.2 Theron Pharmaceuticals Overview 6.9.3 Theron Pharmaceuticals Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.9.4 Theron Pharmaceuticals Bronchodilator Product Description 6.9.5 Theron Pharmaceuticals Recent Developments 6.10 Array BioPharma 6.10.1 Array BioPharma Corporation Information 6.10.2 Array BioPharma Overview 6.10.3 Array BioPharma Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.10.4 Array BioPharma Bronchodilator Product Description 6.10.5 Array BioPharma Recent Developments 6.11 Kyowa Hakko Kirin 6.11.1 Kyowa Hakko Kirin Corporation Information 6.11.2 Kyowa Hakko Kirin Overview 6.11.3 Kyowa Hakko Kirin Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.11.4 Kyowa Hakko Kirin Bronchodilator Product Description 6.11.5 Kyowa Hakko Kirin Recent Developments 6.12 Verona Pharma 6.12.1 Verona Pharma Corporation Information 6.12.2 Verona Pharma Overview 6.12.3 Verona Pharma Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.12.4 Verona Pharma Bronchodilator Product Description 6.12.5 Verona Pharma Recent Developments 6.13 Nycomed Pharma 6.13.1 Nycomed Pharma Corporation Information 6.13.2 Nycomed Pharma Overview 6.13.3 Nycomed Pharma Bronchodilator Sales and Revenue in United States Market (2016-2021) 6.13.4 Nycomed Pharma Bronchodilator Product Description 6.13.5 Nycomed Pharma Recent Developments 7 United States Bronchodilator Production Capacity, Analysis 7.1 United States Bronchodilator Production Capacity, 2016-2027 7.2 Bronchodilator Production Capacity of Key Manufacturers in United States Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Bronchodilator Supply Chain Analysis 9.1 Bronchodilator Industry Value Chain 9.2 Bronchodilator Upstream Market 9.3 Bronchodilator Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Bronchodilator Distributors and Sales Agents in United States Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer

List of Tables Table 1. Key Players of Bronchodilator in United States Market Table 2. Top Bronchodilator Players in United States Market, Ranking by Revenue (2019) Table 3. United States Bronchodilator Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Bronchodilator Revenue Share by Companies, 2016-2021 Table 5. United States Bronchodilator Sales by Companies, (K Doses), 2016-2021 Table 6. United States Bronchodilator Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Bronchodilator Price (2016-2021) & (USD/Dose) Table 8. Manufacturers Bronchodilator Product Type Table 9. List of Tier 1 Bronchodilator Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Bronchodilator Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Short-acting Bronchodilator Table 12. Major Manufacturers of Long-acting Bronchodilator Table 13. By Type – United States Bronchodilator Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Bronchodilator Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Bronchodilator Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Bronchodilator Sales (K Doses), 2016-2021 Table 17. By Type - United States Bronchodilator Sales (K Doses), 2022-2027 Table 18. By Application – United States Bronchodilator Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Bronchodilator Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Bronchodilator Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Bronchodilator Sales (K Doses), 2016-2021 Table 22. By Application - United States Bronchodilator Sales (K Doses), 2022-2027 Table 23. GlaxoSmithKline Corporation Information Table 24. GlaxoSmithKline Description and Major Businesses Table 25. GlaxoSmithKline Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 26. GlaxoSmithKline Bronchodilator Product Table 27. GlaxoSmithKline Recent Developments Table 28. Roche Corporation Information Table 29. Roche Description and Major Businesses Table 30. Roche Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 31. Roche Bronchodilator Product Table 32. Roche Recent Developments Table 33. AstraZeneca Corporation Information Table 34. AstraZeneca Description and Major Businesses Table 35. AstraZeneca Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 36. AstraZeneca Bronchodilator Product Table 37. AstraZeneca Recent Developments Table 38. Boehringer Ingelheim Corporation Information Table 39. Boehringer Ingelheim Description and Major Businesses Table 40. Boehringer Ingelheim Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 41. Boehringer Ingelheim Bronchodilator Product Table 42. Boehringer Ingelheim Recent Developments Table 43. Amgen Corporation Information Table 44. Amgen Description and Major Businesses Table 45. Amgen Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 46. Amgen Bronchodilator Product Table 47. Amgen Recent Developments Table 48. Kissei Pharmaceutical Corporation Information Table 49. Kissei Pharmaceutical Description and Major Businesses Table 50. Kissei Pharmaceutical Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 51. Kissei Pharmaceutical Bronchodilator Product Table 52. Kissei Pharmaceutical Recent Developments Table 53. Mitsubishi Tanabe Pharma Corporation Information Table 54. Mitsubishi Tanabe Pharma Description and Major Businesses Table 55. Mitsubishi Tanabe Pharma Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 56. Mitsubishi Tanabe Pharma Bronchodilator Product Table 57. Mitsubishi Tanabe Pharma Recent Developments Table 58. Sanofi Corporation Information Table 59. Sanofi Description and Major Businesses Table 60. Sanofi Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 61. Sanofi Bronchodilator Product Table 62. Sanofi Recent Developments Table 63. Theron Pharmaceuticals Corporation Information Table 64. Theron Pharmaceuticals Description and Major Businesses Table 65. Theron Pharmaceuticals Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 66. Theron Pharmaceuticals Bronchodilator Product Table 67. Theron Pharmaceuticals Recent Developments Table 68. Array BioPharma Corporation Information Table 69. Array BioPharma Description and Major Businesses Table 70. Array BioPharma Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 71. Array BioPharma Bronchodilator Product Table 72. Array BioPharma Recent Developments Table 73. Kyowa Hakko Kirin Corporation Information Table 74. Kyowa Hakko Kirin Description and Major Businesses Table 75. Kyowa Hakko Kirin Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 76. Kyowa Hakko Kirin Bronchodilator Product Table 77. Kyowa Hakko Kirin Recent Developments Table 78. Verona Pharma Corporation Information Table 79. Verona Pharma Description and Major Businesses Table 80. Verona Pharma Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 81. Verona Pharma Bronchodilator Product Table 82. Verona Pharma Recent Developments Table 83. Nycomed Pharma Corporation Information Table 84. Nycomed Pharma Description and Major Businesses Table 85. Nycomed Pharma Bronchodilator Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 86. Nycomed Pharma Bronchodilator Product Table 87. Nycomed Pharma Recent Developments Table 88. Bronchodilator Production Capacity (K Doses) of Key Manufacturers in United States Market, 2019-2021 (K Doses) Table 89. United States Bronchodilator Capacity Market Share of Key Manufacturers, 2019-2021 Table 90. Bronchodilator Market Opportunities & Trends in United States Market Table 91. Bronchodilator Market Drivers in United States Market Table 92. Bronchodilator Market Restraints in United States Market Table 93. Bronchodilator Raw Materials Table 94. Bronchodilator Raw Materials Suppliers in United States Market Table 95. Typical Bronchodilator Downstream Table 96. Bronchodilator Downstream Clients in United States Market Table 97. Bronchodilator Distributors and Sales Agents in United States Market List of Figures Figure 1. Bronchodilator Product Picture Figure 2. Bronchodilator Segment by Type Figure 3. Bronchodilator Segment by Application Figure 4. United States Bronchodilator Market Overview: 2020 Figure 5. United States Bronchodilator Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Bronchodilator Revenue, 2016-2027 (US$, Mn) Figure 7. Bronchodilator Sales in United States Market: 2016-2027 (K Doses) Figure 8. The Top 3 and 5 Players Market Share by Bronchodilator Revenue in 2020 Figure 9. Short-acting Bronchodilator Product Picture Figure 10. Long-acting Bronchodilator Product Picture Figure 11. By Type - United States Bronchodilator Sales Market Share, 2016-2027 Figure 12. By Type - United States Bronchodilator Revenue Market Share, 2016-2027 Figure 13. By Type - United States Bronchodilator Price (USD/Dose), 2016-2027 Figure 14. Asthma Figure 15. Chronic Obstructive Pulmonary Disease Figure 16. Others Figure 17. By Application - United States Bronchodilator Sales Market Share, 2016-2027 Figure 18. By Application - United States Bronchodilator Revenue Market Share, 2016-2027 Figure 19. By Application - United States Bronchodilator Price (USD/Dose), 2016-2027 Figure 20. GlaxoSmithKline Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Roche Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. AstraZeneca Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Boehringer Ingelheim Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Amgen Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. Kissei Pharmaceutical Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Mitsubishi Tanabe Pharma Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Sanofi Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Theron Pharmaceuticals Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. Array BioPharma Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 30. Kyowa Hakko Kirin Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 31. Verona Pharma Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 32. Nycomed Pharma Bronchodilator Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 33. United States Bronchodilator Production Capacity (K Doses), 2016-2027 Figure 34. Bronchodilator Industry Value Chain Figure 35. Marketing Channels

GlaxoSmithKline Roche AstraZeneca Boehringer Ingelheim Amgen Kissei Pharmaceutical Mitsubishi Tanabe Pharma Sanofi Theron Pharmaceuticals Array BioPharma Kyowa Hakko Kirin Verona Pharma Nycomed Pharma